Jun 25, 2024
976:965
For every 965 shares held, investors received 976. The price per share adjusted from $0.03 to $0.03.
The split itself did not change the total investment value.
iX Biopharma Ltd. (SGX:42C) operates in the Pharmaceuticals: major industry.
iX Biopharma Ltd. company overviewiX Biopharma Ltd.'s most recent stock split was on June 25, 2024. It was a 976-for-965 forward split, so shareholders received 976 shares for every 965 they held.
iX Biopharma Ltd. (SGX:42C) has split its stock 3 times: a 147-for-145 split on June 22, 2016, a 749-for-740 split on June 29, 2021, and a 976-for-965 split on June 25, 2024.
iX Biopharma Ltd. has split its stock 3 times. This history records 3 forward splits between June 22, 2016 and June 25, 2024.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In iX Biopharma Ltd.'s 976-for-965 split on June 25, 2024, every 965 shares became 976 shares.
iX Biopharma Ltd. has not announced a new split in our records. Its most recent split was on June 25, 2024, 2 years ago. Companies announce splits in advance, and any new SGX:42C split will appear on this page.
Already premium?